Comment
|
Neuronal NOS is specifically upregulated in motoneurons following Fas activation and its activity is essential for Fas-induced death. Fas activation in motoneurons leads to the transcription and translation of nNOS.
|
Formal Description Interaction-ID: 1391
|
in Fas-activated motoneurons
|
Drugbank entries
|
Show/Hide entries for
FAS
or
NOS1
|
Drugbank
DB00339
|
|
Drugbank
DB00155
|
|
Drugbank
DB01821
|
L-N(Omega)-Nitroarginine-2,4-L-Diaminobu ...
|
Drugbank
DB01942
|
|
Drugbank
DB01997
|
|
Drugbank
DB02027
|
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]P ...
|
Drugbank
DB02044
|
N-(3-(Aminomethyl)Benzyl)Acetamidine
|
Drugbank
DB02077
|
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Pr ...
|
Drugbank
DB02143
|
N-Isopropyl-N'-Hydroxyguanidine
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB02727
|
N-Butyl-N'-Hydroxyguanidine
|
Drugbank
DB02944
|
|
Drugbank
DB02991
|
S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Iso ...
|
Drugbank
DB03014
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03147
|
Flavin-Adenine Dinucleotide
|
Drugbank
DB03247
|
|
Drugbank
DB03449
|
N-(4-(2-((3-Chlorophenylmethyl)Amino)Eth ...
|
Drugbank
DB03461
|
2'-Monophosphoadenosine 5'-Diphosphoribo ...
|
Drugbank
DB03707
|
S-Ethyl-N-Phenyl-Isothiourea
|
Drugbank
DB03710
|
N5-(1-Imino-3-Butenyl)-L-Ornithine
|
Drugbank
DB03892
|
|
Drugbank
DB04223
|
|
Drugbank
DB08018
|
N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2 ...
|
Drugbank
DB08019
|
N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2 ...
|
Drugbank
DB00155
|
|
Drugbank
DB01821
|
L-N(Omega)-Nitroarginine-2,4-L-Diaminobu ...
|
Drugbank
DB01942
|
|
Drugbank
DB01997
|
|
Drugbank
DB02027
|
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]P ...
|
Drugbank
DB02077
|
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Pr ...
|
Drugbank
DB02143
|
N-Isopropyl-N'-Hydroxyguanidine
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB02727
|
N-Butyl-N'-Hydroxyguanidine
|
Drugbank
DB02944
|
|
Drugbank
DB03014
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03147
|
Flavin-Adenine Dinucleotide
|
Drugbank
DB03247
|
|
Drugbank
DB03461
|
2'-Monophosphoadenosine 5'-Diphosphoribo ...
|
Drugbank
DB03710
|
N5-(1-Imino-3-Butenyl)-L-Ornithine
|
Drugbank
DB03892
|
|
Drugbank
DB04223
|
|
|
|
Comment
|
MAP kinase activation plays a role in Fas-induced death. There was an increase in relative levels of phospho-p38 following Fas activation but no change in the levels of phospho-JNK.
|
Formal Description Interaction-ID: 1402
|
in Fas-activated motoneurons
|
Drugbank entries
|
Show/Hide entries for
FAS
or
MAPK14
|
Drugbank
DB00339
|
|
Drugbank
DB01761
|
4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin- ...
|
Drugbank
DB01807
|
N-[(3z)-5-Tert-Butyl-2-Phenyl-1,2-Dihydr ...
|
Drugbank
DB01948
|
1-(2,6-Dichlorophenyl)-5-(2,4-Difluoroph ...
|
Drugbank
DB01953
|
|
Drugbank
DB01988
|
6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphtha ...
|
Drugbank
DB02195
|
3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin- ...
|
Drugbank
DB02277
|
1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl ...
|
Drugbank
DB02352
|
3-(Benzyloxy)Pyridin-2-Amine
|
Drugbank
DB02873
|
1-(2,6-Dichlorophenyl)-5-(2,4-Difluoroph ...
|
Drugbank
DB02984
|
4-[3-Methylsulfanylanilino]-6,7-Dimethox ...
|
Drugbank
DB03044
|
1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Y ...
|
Drugbank
DB03110
|
|
Drugbank
DB03980
|
4-(Fluorophenyl)-1-Cyclopropylmethyl-5-( ...
|
Drugbank
DB04338
|
|
Drugbank
DB04632
|
4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROP ...
|
Drugbank
DB04797
|
|
Drugbank
DB06882
|
1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyr ...
|
Drugbank
DB06940
|
N-ethyl-4-{[5-(methoxycarbamoyl)-2-methy ...
|
Drugbank
DB06991
|
N-[2-methyl-5-(methylcarbamoyl)phenyl]-2 ...
|
Drugbank
DB07138
|
5-(2,6-dichlorophenyl)-2-[(2,4-difluorop ...
|
Drugbank
DB07307
|
N-cyclopropyl-4-methyl-3-[1-(2-methylphe ...
|
Drugbank
DB07459
|
4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMID ...
|
Drugbank
DB07607
|
4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINY ...
|
Drugbank
DB07811
|
N-cyclopropyl-2',6-dimethyl-4'-(5-methyl ...
|
Drugbank
DB07829
|
4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PY ...
|
Drugbank
DB07832
|
4-{4-[(5-hydroxy-2-methylphenyl)amino]qu ...
|
Drugbank
DB07833
|
N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl ...
|
Drugbank
DB07834
|
N-(cyclopropylmethyl)-2'-methyl-5'-(5-me ...
|
Drugbank
DB07835
|
N~3~-cyclopropyl-N~4~'-(cyclopropylmethy ...
|
Drugbank
DB07941
|
3-{3-bromo-4-[(2,4-difluorobenzyl)oxy]-6 ...
|
Drugbank
DB07942
|
2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazo ...
|
Drugbank
DB07943
|
2-{4-[5-(4-chlorophenyl)-4-pyrimidin-4-y ...
|
Drugbank
DB08064
|
N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-C ...
|
Drugbank
DB08068
|
N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PH ...
|
Drugbank
DB08091
|
3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDI ...
|
Drugbank
DB08092
|
3-FLUORO-N-1H-INDOL-5-YL-5-MORPHOLIN-4-Y ...
|
Drugbank
DB08093
|
3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE
|
Drugbank
DB08095
|
3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY ...
|
Drugbank
DB08096
|
8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROP ...
|
Drugbank
DB08097
|
2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENY ...
|
Drugbank
DB08242
|
N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3, ...
|
Drugbank
DB08349
|
N-cyclopropyl-3-{[1-(2,4-difluorophenyl) ...
|
Drugbank
DB08351
|
N-cyclopropyl-4-methyl-3-{2-[(2-morpholi ...
|
Drugbank
DB08352
|
6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N ...
|
Drugbank
DB08395
|
2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2 ...
|
Drugbank
DB08423
|
[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4 ...
|
Drugbank
DB08424
|
[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4 ...
|
Drugbank
DB08521
|
4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFI ...
|
Drugbank
DB08522
|
4-(4-FLUOROPHENYL)-1-CYCLOROPROPYLMETHYL ...
|
Drugbank
DB08730
|
3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDI ...
|
Drugbank
DB01761
|
4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin- ...
|
Drugbank
DB01807
|
N-[(3z)-5-Tert-Butyl-2-Phenyl-1,2-Dihydr ...
|
Drugbank
DB01948
|
1-(2,6-Dichlorophenyl)-5-(2,4-Difluoroph ...
|
Drugbank
DB01953
|
|
Drugbank
DB01988
|
6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphtha ...
|
Drugbank
DB02195
|
3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin- ...
|
Drugbank
DB02277
|
1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl ...
|
Drugbank
DB02352
|
3-(Benzyloxy)Pyridin-2-Amine
|
Drugbank
DB02873
|
1-(2,6-Dichlorophenyl)-5-(2,4-Difluoroph ...
|
Drugbank
DB02984
|
4-[3-Methylsulfanylanilino]-6,7-Dimethox ...
|
Drugbank
DB03044
|
1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Y ...
|
Drugbank
DB03110
|
|
Drugbank
DB04338
|
|
Drugbank
DB04632
|
4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROP ...
|
Drugbank
DB04797
|
|
|
|
Comment
|
p38 kinase controls nNOS transcription following Fas activation. Inhibiting p38 activity by SB203580 (a p38 inhibitor) strongly inhibited nNOS upregulation following Fas activation, so that one principal role of p38 in these conditions is to enhance NO production.
|
Formal Description Interaction-ID: 1418
|
in Fas-activated motoneurons
|
Drugbank entries
|
Show/Hide entries for
NOS1
|
Drugbank
DB00155
|
|
Drugbank
DB01821
|
L-N(Omega)-Nitroarginine-2,4-L-Diaminobu ...
|
Drugbank
DB01942
|
|
Drugbank
DB01997
|
|
Drugbank
DB02027
|
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]P ...
|
Drugbank
DB02044
|
N-(3-(Aminomethyl)Benzyl)Acetamidine
|
Drugbank
DB02077
|
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Pr ...
|
Drugbank
DB02143
|
N-Isopropyl-N'-Hydroxyguanidine
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB02727
|
N-Butyl-N'-Hydroxyguanidine
|
Drugbank
DB02944
|
|
Drugbank
DB02991
|
S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Iso ...
|
Drugbank
DB03014
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03147
|
Flavin-Adenine Dinucleotide
|
Drugbank
DB03247
|
|
Drugbank
DB03449
|
N-(4-(2-((3-Chlorophenylmethyl)Amino)Eth ...
|
Drugbank
DB03461
|
2'-Monophosphoadenosine 5'-Diphosphoribo ...
|
Drugbank
DB03707
|
S-Ethyl-N-Phenyl-Isothiourea
|
Drugbank
DB03710
|
N5-(1-Imino-3-Butenyl)-L-Ornithine
|
Drugbank
DB03892
|
|
Drugbank
DB04223
|
|
Drugbank
DB08018
|
N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2 ...
|
Drugbank
DB08019
|
N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2 ...
|
Drugbank
DB00155
|
|
Drugbank
DB01821
|
L-N(Omega)-Nitroarginine-2,4-L-Diaminobu ...
|
Drugbank
DB01942
|
|
Drugbank
DB01997
|
|
Drugbank
DB02027
|
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]P ...
|
Drugbank
DB02077
|
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Pr ...
|
Drugbank
DB02143
|
N-Isopropyl-N'-Hydroxyguanidine
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB02727
|
N-Butyl-N'-Hydroxyguanidine
|
Drugbank
DB02944
|
|
Drugbank
DB03014
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03147
|
Flavin-Adenine Dinucleotide
|
Drugbank
DB03247
|
|
Drugbank
DB03461
|
2'-Monophosphoadenosine 5'-Diphosphoribo ...
|
Drugbank
DB03710
|
N5-(1-Imino-3-Butenyl)-L-Ornithine
|
Drugbank
DB03892
|
|
Drugbank
DB04223
|
|
|
|
Comment
|
Production of NO by nNOS is necessary for Fas to exert its killing effect in motoneurons.
|
Formal Description Interaction-ID: 2455
|
drug/chemical compound
NO
in Fas-activated motoneurons
|
Drugbank entries
|
Show/Hide entries for
NOS1
|
Drugbank
DB00155
|
|
Drugbank
DB01821
|
L-N(Omega)-Nitroarginine-2,4-L-Diaminobu ...
|
Drugbank
DB01942
|
|
Drugbank
DB01997
|
|
Drugbank
DB02027
|
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]P ...
|
Drugbank
DB02044
|
N-(3-(Aminomethyl)Benzyl)Acetamidine
|
Drugbank
DB02077
|
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Pr ...
|
Drugbank
DB02143
|
N-Isopropyl-N'-Hydroxyguanidine
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB02727
|
N-Butyl-N'-Hydroxyguanidine
|
Drugbank
DB02944
|
|
Drugbank
DB02991
|
S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Iso ...
|
Drugbank
DB03014
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03147
|
Flavin-Adenine Dinucleotide
|
Drugbank
DB03247
|
|
Drugbank
DB03449
|
N-(4-(2-((3-Chlorophenylmethyl)Amino)Eth ...
|
Drugbank
DB03461
|
2'-Monophosphoadenosine 5'-Diphosphoribo ...
|
Drugbank
DB03707
|
S-Ethyl-N-Phenyl-Isothiourea
|
Drugbank
DB03710
|
N5-(1-Imino-3-Butenyl)-L-Ornithine
|
Drugbank
DB03892
|
|
Drugbank
DB04223
|
|
Drugbank
DB08018
|
N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2 ...
|
Drugbank
DB08019
|
N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2 ...
|
Drugbank
DB00155
|
|
Drugbank
DB01821
|
L-N(Omega)-Nitroarginine-2,4-L-Diaminobu ...
|
Drugbank
DB01942
|
|
Drugbank
DB01997
|
|
Drugbank
DB02027
|
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]P ...
|
Drugbank
DB02077
|
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Pr ...
|
Drugbank
DB02143
|
N-Isopropyl-N'-Hydroxyguanidine
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB02727
|
N-Butyl-N'-Hydroxyguanidine
|
Drugbank
DB02944
|
|
Drugbank
DB03014
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03147
|
Flavin-Adenine Dinucleotide
|
Drugbank
DB03247
|
|
Drugbank
DB03461
|
2'-Monophosphoadenosine 5'-Diphosphoribo ...
|
Drugbank
DB03710
|
N5-(1-Imino-3-Butenyl)-L-Ornithine
|
Drugbank
DB03892
|
|
Drugbank
DB04223
|
|
|
|
Comment
|
Neuronal NOS is specifically upregulated in motoneurons following Fas activation and its activity is essential for Fas-induced death. Fas activation in motoneurons leads to the transcription and translation of nNOS.
|
Formal Description Interaction-ID: 13496
|
in Fas-activated motoneurons
|
Drugbank entries
|
Show/Hide entries for
FAS
or
NOS1
|
Drugbank
DB00339
|
|
Drugbank
DB00155
|
|
Drugbank
DB01821
|
L-N(Omega)-Nitroarginine-2,4-L-Diaminobu ...
|
Drugbank
DB01942
|
|
Drugbank
DB01997
|
|
Drugbank
DB02027
|
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]P ...
|
Drugbank
DB02044
|
N-(3-(Aminomethyl)Benzyl)Acetamidine
|
Drugbank
DB02077
|
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Pr ...
|
Drugbank
DB02143
|
N-Isopropyl-N'-Hydroxyguanidine
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB02727
|
N-Butyl-N'-Hydroxyguanidine
|
Drugbank
DB02944
|
|
Drugbank
DB02991
|
S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Iso ...
|
Drugbank
DB03014
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03147
|
Flavin-Adenine Dinucleotide
|
Drugbank
DB03247
|
|
Drugbank
DB03449
|
N-(4-(2-((3-Chlorophenylmethyl)Amino)Eth ...
|
Drugbank
DB03461
|
2'-Monophosphoadenosine 5'-Diphosphoribo ...
|
Drugbank
DB03707
|
S-Ethyl-N-Phenyl-Isothiourea
|
Drugbank
DB03710
|
N5-(1-Imino-3-Butenyl)-L-Ornithine
|
Drugbank
DB03892
|
|
Drugbank
DB04223
|
|
Drugbank
DB08018
|
N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2 ...
|
Drugbank
DB08019
|
N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2 ...
|
Drugbank
DB00155
|
|
Drugbank
DB01821
|
L-N(Omega)-Nitroarginine-2,4-L-Diaminobu ...
|
Drugbank
DB01942
|
|
Drugbank
DB01997
|
|
Drugbank
DB02027
|
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]P ...
|
Drugbank
DB02077
|
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Pr ...
|
Drugbank
DB02143
|
N-Isopropyl-N'-Hydroxyguanidine
|
Drugbank
DB02644
|
N-Omega-Propyl-L-Arginine
|
Drugbank
DB02692
|
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
|
Drugbank
DB02727
|
N-Butyl-N'-Hydroxyguanidine
|
Drugbank
DB02944
|
|
Drugbank
DB03014
|
|
Drugbank
DB03144
|
N-Omega-Hydroxy-L-Arginine
|
Drugbank
DB03147
|
Flavin-Adenine Dinucleotide
|
Drugbank
DB03247
|
|
Drugbank
DB03461
|
2'-Monophosphoadenosine 5'-Diphosphoribo ...
|
Drugbank
DB03710
|
N5-(1-Imino-3-Butenyl)-L-Ornithine
|
Drugbank
DB03892
|
|
Drugbank
DB04223
|
|
|
|